| |
Birmingham Hip Resurfacing -
Literature Review
Demographics for X-Ray, Oswestry, McMinn, and Overall McMinn cohorts
Patients in the Overall McMinn cohort were 70.6% men and 29.4% women,
ages 13-86 years (average 53.1 years). The primary diagnosis was
osteoarthritis in 75.0%, dysplasia in 15.8%, avascular necrosis in 4.1%,
inflammatory arthritis in 2.4%, and “other” in 2.7% (Table 4).
|
Table 4: Procedure
Demographics |
| |
X-Ray Cohort |
Oswestry Cohort |
McMinn Cohort |
Overall McMinn |
| Hips |
124 |
1502 |
759 |
2385 |
| Men |
81
(65.3%) |
1082 (72.0%) |
520 (68.5%) |
1683
(70.6%) |
| Women |
43
(34.7%) |
420
(28.0%) |
239
(31.5%) |
702
(29.4%) |
| Age (range) |
52.8
(27.8 - 75.3) |
53.0
(13.4 - 86.5) |
53.3
(21.6 - 79.5) |
53.1
(13.4 - 86.5) |
| Age ≤ 65 years |
111
(89.5%) |
1388
(92.4%) |
692
(91.2%) |
2191
(91.9%) |
| |
|
|
|
|
| Dx: OA |
92
(74.2%) |
1171
(78.0%) |
526
(69.3%) |
1789
(75.0%) |
| Dx: DDH |
22
(17.7%) |
197
(13.1%) |
1580
(20.8%) |
377
(15.8%) |
| Dx: AVN |
7
(5.6%) |
59
(13.9%) |
31
(4.1%) |
97
(4.1%) |
| Dx: Inflammatory |
2
(1.6%) |
39
(2.6%) |
16
(2.1%) |
57
(2.4%) |
| Dx: Other |
1
(0.8%) |
36
(2.4%) |
28
(3.7%) |
65
(2.7%) |
Demographics for X-Ray/Oswestry combined cohort
Patients in the survivorship study (X-ray/Oswestry combined cohort)
ranged in age from 13.4 to 86.5 years (mean 53 years); 72% of the
patients are male, and 28% are female. Of the 1,626 BHR procedures in
this cohort, 1,499 (92%) were performed in patients < 65 years old, and
127 (8%) were performed in patients > 65 years old.
Diagnostic Indications for Unilateral and Bilateral procedures in X-Ray/Oswestry
combined cohort
One thousand one hundred and eleven (1,111) of the X-ray/Oswestry
combined cohort cases (68%) were unilateral procedures and 515 (32%)
were bilateral procedures. The indication for the majority of cases was
osteoarthritis. Table 5 provides the breakdown of unilateral and
bilateral cases by indication.
|
Table 5: Diagnostic Indications for BHR |
|
Diagnosis |
Unilateral |
Bilateral |
Total |
| Osteoarthritis |
849
(76.4%) |
414
(80.4%) |
1263
(77.7%) |
| Dysplasia |
160
(14.4%) |
59
(11.5%) |
219
(13.5%) |
| Avascular necrosis |
52
(4.7%) |
14
(2.7%) |
66
(4.1%) |
| Inflammatory
arthritis |
18
(1.6%) |
23
(4.5%) |
41
(2.4%) |
| Other |
32
(2.9%) |
5
(1.0%) |
37
(2.3%) |
| TOTAL |
1111
(68%) |
515
(32%) |
1626 |
Some of the patients with
bilateral hip replacements were included in different groups depending
on when the second hip procedure was performed (Table 6).
|
Table 6: Hip Procedures |
|
Cohort |
Patients** |
Hips*** |
Unilateral |
Bilateral |
Contralateral Single Hip Cohort* |
Singles |
|
X-Ray |
Oswestry |
McMinn |
| X-Ray |
113 |
124 |
83 |
11 |
- |
11 |
8 |
19 |
| Oswestry |
1301 |
1502 |
1028 |
201 |
11 |
- |
61 |
72 |
| McMinn |
685 |
759 |
542 |
74 |
8 |
61 |
- |
69 |
* Patients with bilateral
hip replacements with the contralateral hip not included in the first
hip replacement’s evaluation cohort.
** Number of patients equals unilateral + bilateral + singles
*** Number of hips equals unilateral + (2 x bilateral) + singles
Demographics: Literature References
The study published by D'Antonio et al. reported findings from a
multicenter study conducted at 22 investigational sites; the study
published by Garino was conducted at 11 investigational sites (Table 7).
|
Table 7: Demograhpics for Literature Reference |
| Author |
Patients |
Procedures |
Age (average) |
Bilateral
Procedures |
| D'Antonio et al. |
458 |
514
-349 ceramic
- 165 control |
53 |
19 |
| Garino JP |
333
(f=132, m=201) |
333 |
52 |
0 |
D’Antonio et al. reported
the indication for THR as osteoarthritis in 399/514 procedures (77.6%)
and avascular necrosis in 82/514 procedures (16%) (Table 8).
|
Table 8: Indications for Use for Literature References |
|
Diagnosis |
D'Antonio |
| Osteoarthritis |
399 |
| Traumatic
Osteoarthritis/ DJD |
21 |
| Avascular necrosis |
82 |
| Other/ Not reported |
12 |
| TOTAL |
514 |
Patient Accounting
The follow-up rates for the Combined X-Ray / Oswestry Cohort, upon which
the effectiveness analyses were performed, at the 1-year, 2-year,
3-year, 4-year, and 5-year postoperative evaluation time points were
76.6%, 77.3%, 88.1%, 88.6%, and 90.8%, respectively. There were 546
procedures (hips) evaluated at 5 years in this cohort (Table 9).
|
Table 9: Patient Accounting Based on the Number of Procedures |
| |
Baseline |
1
Year |
2
Years |
3
Years |
4
Years |
5
Years |
|
Accounting for Survivorship (%
Revision) |
| Cohort |
|
#
Patients observed at beginning of each study year (# revisions,
# censored)1 |
| X-Ray |
- |
124
(1,0) |
123
(0,0) |
123
(1,0) |
122
(0,0) |
122
(0,20)6 |
| Oswestry |
- |
1502
(9,63) |
1430(5,49) |
1376
(4,256) |
1116
(1,321) |
794
(1,392) |
| McMinn |
- |
759
(3,290) |
466
(0,379) |
87
(0,84) |
3
(0,0)7 |
3
(0,0)7 |
|
X-Ray Cohort |
| Expected1,8 |
124 |
123 |
123 |
122 |
122 |
1183 |
| Evaluated2 |
82 |
101 |
51 |
122 |
119 |
112 |
| F/U %2 |
66.1% |
82.1% |
41.4% |
100.0% |
97.5% |
94.9% |
| Evaluated4 |
124 |
- |
- |
- |
- |
108 |
| F/U %4 |
100% |
- |
- |
- |
- |
91.5% |
|
Oswestry Cohort |
| Expected1,8 |
1502 |
1493 |
1484 |
1227 |
885 |
482 |
| Evaluated2 |
1229 |
1137 |
1192 |
1067 |
773 |
434 |
| F/U %2 |
81.8% |
76.2% |
80.3% |
87.0% |
87.3% |
90.0% |
|
X-Ray / Oswestry Cohort |
| Theoretical1 |
1626 |
1626 |
1626 |
1385 |
1045 |
647 |
| Deaths (procedures) |
0 |
2 |
7 |
16 |
18 |
26 |
Revisons
(cumulative) |
0 |
10 |
15 |
20 |
21 |
23 |
| Expected1,8 |
1626 |
1616 |
1607 |
1349 |
1007 |
601 |
| Evaluated2 |
1311 |
1238 |
1243 |
1189 |
892 |
546 |
| F/U %2 |
80.6% |
76.6% |
77.3% |
88.1% |
88.6% |
90.8% |
| |
| F/U +base5 |
1311 |
1067/1304 |
1050/1294 |
944/1046 |
660/729 |
368/397 |
| +base % |
|
82% |
81% |
90% |
91% |
93% |
| F/U -base5 |
315 |
171/312 |
193/313 |
245/303 |
232/281 |
178/204 |
| -base % |
|
55% |
62% |
81% |
83% |
87% |
1 Note that for
the Survivorship data the “year 1” data is starting from day 1 and the
“year 2” data is starting from day 366, etc. but for the OSHIP scores,
the “year 1” data was collected between day 366-730, the “year 2” data
was collected between day 731-1095, etc.
2 Evaluated by OSHIP score.
3 OSHIP score was available for one hip that was revised
shortly after the 5-year follow-up interval, OSHIP data available on
112/119 (94.1%) of hips surviving to 5 years.
4 Evaluated by X-Ray.
5 The follow-up of those who had baseline OSHIP scores
(+base) and those without baseline OSHIP scores (-base).
6 Note that there were 2 revisions in the x-ray cohort at >5
years.
7 There were 5 cases in the McMinn cohort whose implantations
were performed prior to 4/02. These cases should have been part of the
Oswestry cohort, but for unknown reasons were not. Therefore, unlike the
majority of the McMinn cohort, some of these 5 cases have longer term
follow-up.
8 The expected and evaluated values in each interval include
hips with a recorded OSHIP even if the subject died or was revised
during the interval.
For the unilateral patients
in the X-Ray / Oswestry combined cohort, the follow-up rates at the
1-year, 2-year, 3- year, 4-year, and 5-year postoperative evaluation
time points were 75.7%, 76.6%, 88.2%, 88.4%, and 91.1%, respectively
(Table 10).
|
Table 10: Patient Accounting
Summary of the Oswestry and X-Ray Cohorts - Unilateral Based on
Available OSHIP Data |
| |
Baseline |
1
Year |
2
Years |
3
Years |
4
Years |
5
Years |
| Theoretical |
1111 |
1103 |
1100 |
927 |
395 |
395 |
| OSHIP data |
892 |
835 |
842 |
818 |
607 |
360 |
| % |
80.3 |
75.7 |
76.5 |
88.2 |
88.4 |
91.1 |
Accounting identified in the
literature references were as provided in Table 11.
|
Table 11: Patient Accounting: Literature References |
| Author |
Mean follow-up
(range) |
Number of hips
(patients) included |
D'Antonio
|
35.2 mo (24 - 48 mo)
for ceramic on ceramic.
33.6 mo (24 - 48 mo) for control (metal on polythylene)
|
• 335 hips (307 pts)
at 24 mos
• 243 hips (227 pts) at 36 mos
• 72 hips (71 pts) at 48 mos
165 control THR procedures (161 patients),
• 149 hips (147 pts) at 24 mos
• 111 hips (111 pts) at 36 mos
• 26 hips (26 pts) at 48 mos |
| Garino |
Range 18 - 36 months |
"100% follow-up for
all 333 procedures" |
Return to BHR Literature Review
Back to Patient Education - Hip
2/4/2007
OUR
SERVICES | PATIENT EDUCATION
| ABOUT DR. ROGERSON
CLINIC INFORMATION |
OUR TEAM | CURRICULUM VITAE

|